Silence Therapeutics PLC
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 146.7 | 115.9 | 82.4 | 76.9 | 54.3 | 57.1 | 12.6 | 7.5 | 6.8 | 10.5 | 3.2 | 2.3 | 4.3 | 9.1 | 10.7 | 14.0 | 14.6 | 2.6 | 1.7 | 3.5 | 3.3 | 140.4 | 90.6 | 282.0 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 70.1 | 73.3 | 33.1 | 37.7 | 83.1 | 47.5 | – | 3.2 | 8.3 | 4.5 | 5.4 | 6.1 | 10.4 | 2.0 | 2.6 | 3.0 | 1.0 | – | 1.0 | 1.1 | 1.5 | 1.7 | 4.5 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 110.9 | – | 70.0 | 48.0 | 51.2 | 8.7 | 4.2 | 1.3 | 7.4 | 1.2 | 1.3 | 2.3 | 6.4 | 5.9 | 8.8 | 11.5 | 0.3 | -0.8 | – | 0.0 | 124.1 | 84.5 | 164.8 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 2,335.6 | – | – | 446.0 | 226.3 | 129.5 | 59.2 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.0% | -1.8% | -3.6% | 0.2% | 0.4% | 0.8% | 1.7% | -25.9% | -31.8% | -25.0% | -52.7% | -69.1% | -33.8% | -17.1% | -12.9% | -10.6% | -16.2% | -55.2% | -141.6% | -86.3% | -85.4% | -65.0% | -78.7% | -24.4% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | -899.7% | – | – | – | – | – | – | – | – | – | – | – | -263.6% | -49.2% | 31.3% | 34.2% | 30.0% | 39.7% | 39.9% | 45.3% | 45.3% | 43.9% | 37.8% | 43.3% | 52.4% | 54.2% | 59.3% | 71.1% | 60.4% | 51.1% | 76.5% | 73.0% | 82.4% | 92.6% | 61.6% | 66.4% | 51.0% | |
| – | – | – | -1,528.1% | – | – | – | – | – | – | – | – | – | – | – | -1,958.2% | -929.8% | -654.3% | -473.2% | -431.5% | -411.1% | -369.0% | -309.5% | -298.4% | -302.8% | -277.7% | -219.5% | -168.4% | -168.6% | -195.5% | -144.9% | -235.5% | -305.8% | -118.6% | -307.4% | -366.8% | -396.1% | -15,838.7% | -9,396.6% | -10,880.2% | |
| – | – | – | -1,173.4% | – | – | – | – | – | – | – | – | – | – | – | -1,611.6% | -792.2% | -594.0% | -440.4% | -408.4% | -373.8% | -317.4% | -258.0% | -244.7% | -223.9% | -231.4% | -185.8% | -144.9% | -152.0% | -170.5% | -119.1% | -191.3% | -303.5% | -73.5% | -248.8% | -336.1% | -325.1% | -15,667.6% | -9,243.0% | -9,759.2% | |
| – | – | – | -1,161.7% | – | – | – | – | – | – | – | – | – | – | – | 893.3% | 6.3% | -206.0% | -293.4% | 17.3% | 24.0% | 44.1% | 21.4% | -192.6% | -216.0% | -261.9% | -169.1% | -160.1% | -147.1% | -155.3% | -137.5% | -148.1% | -236.5% | -141.9% | -237.8% | -303.4% | -280.1% | -9,121.3% | -7,126.6% | -6,893.2% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| -14.5% | -15.6% | -18.2% | -19.0% | -10.4% | -3.1% | -7.3% | -10.9% | -33.1% | -52.5% | -66.9% | -66.0% | -89.7% | -93.7% | -76.0% | -81.1% | – | -359.3% | -391.4% | -175.6% | -259.3% | -462.2% | -969.3% | – | -105.9% | -183.4% | -259.2% | -338.4% | -213.1% | -196.7% | -22.6% | -36.0% | -62.7% | -28.7% | – | -92.7% | -109.6% | -172.0% | -172.4% | -155.8% | |
| -14.0% | -15.1% | -17.2% | -18.0% | -9.9% | -2.9% | -6.7% | -10.1% | -29.8% | -47.3% | -60.5% | -59.7% | -40.7% | -42.5% | -21.0% | -22.4% | – | -37.9% | – | -41.3% | -45.7% | -41.0% | -44.6% | -46.7% | -29.2% | -37.7% | -45.6% | -44.7% | -43.5% | -36.2% | -14.4% | -21.5% | -35.0% | -19.0% | -35.2% | -52.8% | -55.3% | -81.5% | -74.0% | -56.3% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | -13 | -13 | -10 | -10 | – | -27 | – | -71 | -71 | -73 | -59 | -52 | -90 | -54 | -47 | -30 | -59 | -69 | -143 | -109 | -62 | -97 | -65 | – | -82 | -11 | -5.6 | -72 | |
| 97.1% | 97.1% | 94.6% | 94.6% | 95.2% | 95.2% | 92.4% | 92.4% | 90.2% | 90.2% | 90.5% | 90.5% | 45.4% | 45.4% | 27.6% | 27.6% | – | 10.5% | – | 23.5% | 17.6% | 8.9% | 4.6% | -5.7% | 27.5% | 20.5% | 17.6% | 13.2% | 20.4% | 18.4% | 63.7% | 59.6% | 55.8% | 66.1% | -60.8% | 57.0% | 50.5% | 47.4% | 42.9% | 36.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | – | 0.0 | – | 0.0 | 0.0 | 0.0 | 0.0 | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | 0.0 | 0.0 | 0.0 | 0.0 | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -0.34 | -0.36 | -0.38 | -0.40 | -0.23 | -0.07 | -0.14 | -0.21 | -0.49 | -0.78 | -0.77 | -0.76 | -0.71 | -0.74 | -0.78 | -0.83 | -0.93 | -1.13 | -1.23 | -1.39 | -1.42 | -1.33 | -3.88 | -3.91 | -3.30 | -3.38 | -3.59 | -3.44 | -3.43 | -3.28 | -2.41 | -2.60 | -3.78 | -1.97 | -4.15 | -5.54 | -5.16 | -6.81 | -5.41 | -3.81 | |
| – | – | – | 0.03 | – | – | – | – | – | – | – | – | – | – | – | 0.05 | 0.12 | 0.19 | 0.28 | 0.34 | 0.38 | 0.42 | 1.50 | 1.60 | 1.47 | 1.46 | 1.93 | 2.37 | 2.25 | 1.92 | 2.03 | 1.36 | 1.25 | 2.69 | 1.67 | 1.65 | 1.59 | 0.04 | 0.06 | 0.04 | |
| 2.33 | 2.33 | 2.08 | 2.08 | 2.24 | 2.24 | 1.88 | 1.88 | 1.49 | 1.49 | 1.14 | 1.14 | 0.79 | 0.79 | 1.03 | 1.03 | – | 0.31 | 0.31 | 0.79 | 0.55 | 0.29 | 0.40 | -0.48 | 3.11 | 1.84 | 1.38 | 1.02 | 1.61 | 1.67 | 10.68 | 7.22 | 6.02 | 6.88 | -7.16 | 5.98 | 4.70 | 3.96 | 3.14 | 2.44 | |
| -0.44 | -0.45 | -0.42 | -0.39 | -0.41 | -0.42 | -0.51 | -0.60 | -0.66 | -0.72 | -0.74 | -0.77 | -0.32 | 0.07 | 0.26 | 0.46 | 0.01 | -0.39 | -0.82 | 0.06 | 0.09 | 0.18 | 0.32 | -3.08 | -3.18 | -3.83 | -3.26 | -3.80 | -3.32 | -2.98 | -2.79 | -2.02 | -2.95 | -3.81 | -3.97 | -5.00 | -4.44 | -3.96 | -4.17 | -2.69 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.